Clementia Pharmaceutical's clinical trial for Palovarotene, a potential treatment to prevent FOP bone formation during flare-ups, began recruiting participants in July. The newsletter also discusses updates on fundraising efforts worldwide for FOP research and support programs, as well as information on nominating new board members and renewing IFOPA membership. The IFOPA thanks readers for their ongoing support in pursuing a cure for FOP while helping individuals and families through education, awareness and advocacy.
Clementia Pharmaceutical's clinical trial for Palovarotene, a potential treatment to prevent FOP bone formation during flare-ups, began recruiting participants in July. The newsletter also discusses updates on fundraising efforts worldwide for FOP research and support programs, as well as information on nominating new board members and renewing IFOPA membership. The IFOPA thanks readers for their ongoing support in pursuing a cure for FOP while helping individuals and families through education, awareness and advocacy.
Clementia Pharmaceutical's clinical trial for Palovarotene, a potential treatment to prevent FOP bone formation during flare-ups, began recruiting participants in July. The newsletter also discusses updates on fundraising efforts worldwide for FOP research and support programs, as well as information on nominating new board members and renewing IFOPA membership. The IFOPA thanks readers for their ongoing support in pursuing a cure for FOP while helping individuals and families through education, awareness and advocacy.
Dear FOP family and friends, The big news this quarter is that Clementia Pharmaceuticals clinical trial for Palovarotene began to recruit participants on July 14th. Palovarotene is being tested to fnd out whether it helps prevent FOP bone from forming during a fare-up. I invite you to read about the clinical trial, if you havent already, and if you or your family member has FOP, I especially encourage you to learn more. Also in this issue is information about the Quarterly in Honor Report. This report will be provided when a donor makes a donation in the honor of a person with FOP. Previously, donations made in honor of a FOP person were not shared unless the donor requsted the honoree to be notifed. We want to give honorees the opportunity to be more proactive to thank those who donate in their honor. Dont forget to give us your updated contact information so that you can receive this report. Find lots more recent news from the IFOPA & FOP community: Reports from the frst FOP meeting in Russia and the summer FOPev meeting in Germany Creative family fundraisers around the world are providing monies for FOP research, IFOPA programs, and LIFE Award scholarships. Inspiring articles about some of our FOP members The IFOPA is recruiting nominees for the 2015 - 2016 two year term on the Board of Directors. Are you interested? Its that time of year to renew your IFOPA membership. You can now renew online. Find details in this article International Fibrodysplasia Ossificans Progressiva Association Fund Research, Find a Cure, Support Families Visit www.ifopa.org to learn about Fibrodysplasia Ossifcans Progressiva 2 membership article. Finally, a reminder that your gifts of $300.00 or more will qualify you to receive a Boy of Bone limited edition book. Thank you for your interest in IFOPA news and your continuing support of the IFOPA. We need each of you, and with your help we will pursue our mission to fund research to fnd a cure for FOP while supporting individuals and their families through education, public awareness and advocacy. Best regards, Marilyn Hair Chair, IFOPA Board of Directors International Fibrodysplasia Ossificans Progressiva Association Fund Research, Find a Cure, Support Families Visit www.ifopa.org to learn about Fibrodysplasia Ossifcans Progressiva 9-4-14